The Ensign Group, Inc.

ENSG Healthcare Medical Care Facilities

The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.

Revenue
+14.5%
EPS
+23.6%
Free cash flow
+89.2%
Total debt
+39.2%

Quarter to September 2026, against a year earlier

179.94 2.45 −1.34%
Market cap
$10.6B
P/E
26.3×
Fwd P/E
25.4×
Dividend yield
0.14%
F-score
7/9
Altman Z
3.57
Beneish M
−2.57
Dividend safety
92/100
Older periods Dec '25 Mar '26 Jun '26 Sep '26
P/E ratio

+8 more quarters

28.99 31.83 24.40 24.87
P/S ratio
1.97 2.21 1.69 1.75
P/FCF ratio
26.93 28.67 22.17 19.50
P/Operating CF
54.46 116.23 54.03 41.40
P/B ratio
4.47 4.91 3.80 3.88
EV/Sales
1.89 2.12 1.66 1.72
EV/EBITDA
18.00 20.02 15.63 15.46
EV/FCF
25.77 27.55 21.74 19.13
Current Ratio
1.42 1.56 1.21 1.20
Net Debt/EBITDA
(2.84) (2.95) (1.17) (1.13)
Debt/Equity
0.06 0.06 0.06 0.08
Earnings Yield
3.45% 3.14% 4.10% 4.02%
Free Cash Flow Yield
3.71% 3.49% 4.51% 5.13%
Free Cash Flow per Share
2.33 1.12 2.06 3.33
Book value per Share
39.00 41.02 42.19 44.33
Free Cash Flow
133.48 64.68 119.13 192.63
EV/EBIT
22.46 24.93 19.49 19.15
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026